Prediction Case File
YouTubeEvaluation Complete

Friends! In this video, I'm going to discuss 2 Growth stocks to Buy with MASSIVE Upside potential.

2 extracted signals · 2 resolved · 0 still active

The Patient Investor profile imageThe Patient InvestorIndependent analyst profile
Source published
30 Dec 2025, 00:35 UTC
Recorded by Tahlil Plus
18 May 2026, 20:23 UTC
Video preview for Friends! In this video, I'm going to discuss 2 Growth stocks to Buy with MASSIVE Upside potential.
Source overview

AI-generated source summary

The analysis covers several retail favorite stocks, with a focus on Grab (GRAB) showing strong growth and financial improvement, making it a potentially good speculative investment despite its current losses. Nebius (NBIS) is also discussed, highlighting its strong revenue growth but also its increasing net loss, making it a riskier prospect for investors.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Evaluation Complete
Signals
2
Extracted from this source
Open
0
Still being tracked
Successful
0
Resolved successfully
Failed
2
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
0%
2 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  3. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

  4. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  5. Market predictions extracted

    2 eligible signals linked to this case.

  6. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

Analyst snapshot

The Patient Investor

Platform-wide history, separate from this source evaluation.

Reliability
47.6
Tracked signals
324
Historical success
34.4%
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail